DudeDiligence.

Rezolute, Inc

RZLTNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

Shares on issue

96.7M

From 53.2M in June 2024

a raise that quarter, at its price

Newest

$400.0M

S-3 of 2026-11-05. 1 prospectus supplement filed under it since.

None

No at-the-market programme on file in the last 30 months.

Warrants

888K

Warrants of every class, exercise price $22.10.

Cash

5.5 quarters

$90.0M cash on hand.

Raised
DateWhatSharesPriceGrossFiling
2026-11-13Public offering incl. 3.80M pre-funded25,840,976$3.87not available424B5 ↗
2025-06-13Private placementnot available$3.25$4.2M8-K ↗
2025-04-23Public offering incl. 6.91M pre-funded27,692,308$3.25$90.0M424B5 ↗
2024-06-25Private placement1,500,000$4.00$6.0M8-K ↗
2024-06-13Public offeringnot available$4.00$60.0M424B5 ↗